Salivary Transcriptome Diagnostics for Oral Cancer Detection

Purpose: Oral fluid (saliva) meets the demand for noninvasive, accessible, and highly efficient diagnostic medium. Recent discovery that a large panel of human RNA can be reliably detected in saliva gives rise to a novel clinical approach, salivary transcriptome diagnostics. The purpose of this study is to evaluate the diagnostic value of this new approach by using oral squamous cell carcinoma (OSCC) as the proof-of-principle disease. Experimental Design: Unstimulated saliva was collected from patients (n = 32) with primary T1/T2 OSCC and normal subjects (n = 32) with matched age, gender, and smoking history. RNA isolation was done from the saliva supernatant, followed by two-round linear amplification with T7 RNA polymerase. Human Genome U133A microarrays were applied for profiling human salivary transcriptome. The different gene expression patterns were analyzed by combining a t test comparison and a fold-change analysis on 10 matched cancer patients and controls. Quantitative polymerase chain reaction (qPCR) was used to validate the selected genes that showed significant difference (P < 0.01) by microarray. The predictive power of these salivary mRNA biomarkers was analyzed by receiver operating characteristic curve and classification models. Results: Microarray analysis showed there are 1,679 genes exhibited significantly different expression level in saliva between cancer patients and controls (P < 0.05). Seven cancer-related mRNA biomarkers that exhibited at least a 3.5-fold elevation in OSCC saliva (P < 0.01) were consistently validated by qPCR on saliva samples from OSCC patients (n = 32) and controls (n = 32). These potential salivary RNA biomarkers are transcripts of IL8, IL1B, DUSP1, HA3, OAZ1, S100P, and SAT. The combinations of these biomarkers yielded sensitivity (91%) and specificity (91%) in distinguishing OSCC from the controls. Conclusions: The utility of salivary transcriptome diagnostics is successfully demonstrated in this study for oral cancer detection. This novel clinical approach could be exploited to a robust, high-throughput, and reproducible tool for early cancer detection. Salivary transcriptome profiling can be applied to evaluate its usefulness for other major disease applications as well as for normal health surveillance.

[1]  Kharchenko Sv,et al.  Regulation of the RNAse activity of the saliva in healthy subjects and in stomach cancer , 1989 .

[2]  M S Pepe,et al.  Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.

[3]  L. Moretti,et al.  Expression of c-myb protooncogene and other cell cycle-related genes in normal and neoplastic human colonic mucosa. , 1987, Cancer research.

[4]  D. Bell,et al.  Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. , 1997, The American journal of medicine.

[5]  K. Rieger-Christ,et al.  Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection , 2003, Cancer.

[6]  D. Malamud.  Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come. , 1997, The American journal of medicine.

[7]  F. Ghezzo,et al.  Enhancement of calcyclin gene RNA expression in squamous cell carcinoma of the oral mucosa, but not in benign lesions. , 1997, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[8]  D. E. Henson,et al.  Molecular Pathology of Early Cancer , 1999 .

[9]  M. Chou,et al.  Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas. , 2000, Oral oncology.

[10]  D. Ginzinger.  Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. , 2002, Experimental hematology.

[11]  N. Hamajima,et al.  [Genetic polymorphisms related to interleukin-1 beta production and disease risk]. , 2003, [Nihon koshu eisei zasshi] Japanese journal of public health.

[12]  Yusuke Nakamura,et al.  Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway , 2001, Oncogene.

[13]  I. Satman,et al.  Salivary peroxidase activity in whole saliva of patients with insulin-dependent (type-1) diabetes mellitus. , 1996, Journal of clinical periodontology.

[14]  C. Smith,et al.  Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  R. Renger,et al.  Use of stepwise regression in medical education research. , 1994, Academic medicine : journal of the Association of American Medical Colleges.

[16]  M. Navazesh,et al.  Methods for Collecting Saliva , 1993, Annals of the New York Academy of Sciences.

[17]  W. Hong,et al.  Focus on head and neck cancer. , 2004, Cancer cell.

[18]  H. Vogel,et al.  Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. , 2003, Cancer research.

[19]  J. Russo,et al.  S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. , 2000, International journal of oncology.

[20]  H. Lawrence,et al.  Salivary markers of systemic disease: noninvasive diagnosis of disease and monitoring of general health. , 2002, Journal.

[21]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.

[22]  Joel B Epstein,et al.  Advances in the diagnosis of oral premalignant and malignant lesions. , 2002, Journal.

[23]  J. Epstein,et al.  The use of exfoliative cell samples to map clonal genetic alterations in the oral epithelium of high-risk patients. , 1997, Cancer research.

[24]  G. Grunkemeier,et al.  Receiver operating characteristic curve analysis of clinical risk models. , 2001, The Annals of thoracic surgery.

[25]  S. Bettuzzi,et al.  Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. , 2000, Cancer research.

[26]  R. Todd,et al.  Induction of epithelial differentiation and DNA demethylation in hamster malignant oral keratinocyte by ornithine decarboxylase antizyme , 2001, Oncogene.

[27]  M. Gorsky,et al.  Proliferative verrucous leukoplakia: a follow-up study of 54 cases. , 1997, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[28]  A Mashberg,et al.  Early diagnosis of asymptomatic oral and oropharyngeal squamouscancers , 1995, CA: a cancer journal for clinicians.

[29]  F. A. Benko,et al.  Circulating RNA as a Tumor Marker , 2001, Annals of the New York Academy of Sciences.

[30]  H. Watanabe,et al.  Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines. , 2002, Oral oncology.

[31]  M. Wax,et al.  Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer , 1998 .

[32]  R. Todd,et al.  Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis , 2001, Oncogene.

[33]  S. V. Kharchenko,et al.  [Regulation of the RNAse activity of the saliva in healthy subjects and in stomach cancer]. , 1989, Izvestiia Akademii nauk SSSR. Seriia biologicheskaia.

[34]  B. Sheu,et al.  T lymphocytes and cytokine production in ascitic fluid of ovarian malignancies. , 1999, Journal of the Formosan Medical Association = Taiwan yi zhi.

[35]  Spyro Mousses,et al.  Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. , 2002, Cancer research.

[36]  Yusuke Nakamura,et al.  Identification and allelic frequencies of novel single-nucleotide polymorphisms in the DUSP1 and BTG1 genes , 2001, Journal of Human Genetics.

[37]  Allison Jones,et al.  cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells , 2003, Oncogene.

[38]  A Kingman,et al.  The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[39]  T. Liu,et al.  Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer , 2000, Genes, chromosomes & cancer.

[40]  Carlo Montemagno,et al.  Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. , 2004, Archives of otolaryngology--head & neck surgery.

[41]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[42]  P. Bunn.  Early detection of lung cancer using serum RNA or DNA markers: ready for "prime time" or for validation? , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Eithne Costello,et al.  Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent , 2003, The Journal of pathology.

[44]  S Lippman,et al.  Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. , 2001, The Journal of molecular diagnostics : JMD.

[45]  David Sidransky,et al.  Emerging molecular markers of cancer , 2002, Nature Reviews Cancer.

[46]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Wong,et al.  RNA Profiling of Cell-free Saliva Using Microarray Technology , 2004, Journal of dental research.

[48]  G. Makhatadze,et al.  Cloning, overexpression, purification, and spectroscopic characterization of human S100P , 1998, Protein science : a publication of the Protein Society.

[49]  渡辺 仁資.  Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines , 2002 .

[50]  Rork Kuick,et al.  Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. , 2003, Cancer research.

[51]  J. Goedert,et al.  Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. , 2003, Gastroenterology.

[52]  S. Lemon,et al.  Classification and regression tree analysis in public health: Methodological review and comparison with logistic regression , 2003, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[53]  Bettuzzi Saverio,et al.  Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. , 2000 .

[54]  T. Bundgaard,et al.  Delay in the diagnosis of oral squamous cell carcinoma. , 1995, Clinical otolaryngology and allied sciences.

[55]  R. Haug.  Oral diagnostic testing for detecting human immuno-deficiency virus-1 antibodies: A technology whose time has come , 1998 .

[56]  D. Sidransky,et al.  Nucleic acid-based methods for the detection of cancer. , 1997, Science.

[57]  J. Sudbø,et al.  DNA content as a prognostic marker in patients with oral leukoplakia. , 2001, The New England journal of medicine.

[58]  S. Lippman,et al.  Predicting cancer development in oral leukoplakia: ten years of translational research. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[59]  H. Mulcahy,et al.  Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients , 2004, Cancer and Metastasis Reviews.

[60]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.